Dedicated to all those anons that dismiss COVID as just the flu or a cold

https://nypost.com/2021/01/18/1-in-8-recovered-covid-19-patients-die-within-5-months-study/

One in eight recovered COVID patients die from illness complications within 5 months: UK study

By Yaron SteinbuchJanuary 18, 2021 | 8:35am

Almost a third of recovered COVID-19 patients in a UK study ended up back in the hospital within five months — and up to one in eight died of complications from the illness, according to a report.

Researchers at the UK’s Leicester University and the Office for National Statistics found that out of 47,780 people discharged from the hospital, 29.4 percent were readmitted within 140 days, the Telegraph reported.

Of the total, 12.3 percent ended up dying, it added.

Respiratory disease was diagnosed in 14,140 of the COVID cases after discharge, with 6,085 of the diagnoses in patients who had no history of respiratory conditions.

The mean age of study participants was 65 years.

[Moar at website]

=

Journal article:

https://www.medrxiv.org/content/10.1101/2021.01.15.21249885v1.full.pdf

https://www.medrxiv.org/content/10.1101/2021.01.15.21249885v1

doi: https://doi.org/10.1101/2021.01.15.21249885

Epidemiology of post-COVID syndrome following hospitalisation with

coronavirus: a retrospective cohort study

Daniel Ayoubkhani, Kamlesh Khunti, Vahé Nafilyan, Thomas Maddox, Ben Humberstone, Sir Ian Diamond, Amitava Banerjee

More info for all those anons that dismiss COVID as just the flu or a cold

https://www.medpagetoday.com/infectiousdisease/covid19/90622

'''Acute Brain Dysfunction Prolonged in COVID-19 ICU Patients

— 'COVID in the ICU is like a delirium factory

by Judy George, Senior Staff Writer, MedPage Today January 11, 2021

Acute brain dysfunction coma or delirium occurred frequently and was prolonged in critically ill COVID-19 patients, a large multicenter cohort study showed.

Of more than 2,000 COVID-19 ICU patients in 14 countries, 82% were comatose for a median of 10 days, reported Rafael Badenes, MD, PhD, of the University of Valencia in Spain, and co-authors in Lancet Respiratory Medicine. For the 55% showing delirium, the median duration was 3 days.

Acute brain dysfunction lasted a median of 12 days, twice what's usually seen with other ICU patients. Benzodiazepine use and family visits were identified as modifiable risk factors for COVID-19 delirium.

Prolonged acute brain dysfunction is "a harbinger of bad outcomes," said co-author Wes Ely, MD, of Vanderbilt University Medical Center in Nashville. Earlier research has shown that delirium duration is a predictor of mortality, length of stay, cost of care, and acquired dementia, he noted.

"What we're learning is that COVID in the ICU is like a delirium factory," Ely told MedPage Today. "It's a reason to have our hackles up and say OK, what are we going to do about it?"

The study looked at 2,088 COVID-19 patients admitted to 69 ICUs before April 28, 2020. Median patient age was 64, with median Simplified Acute Physiology Score (SAPS) II of 40 on admission; most were men (71.7%) and white (76.5%). Patients who were moribund or who had life-support measures withdrawn within 24 hours of ICU admission and those with pre-existing mental illness, neurodegenerative disorders, or brain damage were excluded.

[Moar at website]

------–

Journal article:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30552-X/fulltext

https://www.thelancet.com/action/showPdf?pii=S2213-2600%2820%2930552-X

DOI:https://doi.org/10.1016/S2213-2600(20)30552-X

Prevalence and risk factors for delirium in critically ill

patients with COVID-19 (COVID-D): a multicentre cohort

study

Brenda T Pun, DNP; Prof Rafael Badenes, MD; Gabriel Heras La Calle, MD; Onur M Orun, MS; Wencong Chen, PhD; Rameela Raman, PhD; et al.